Cargando…

Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome

Detalles Bibliográficos
Autores principales:	Schoof, Melanie, Kordes, Uwe, Volk, Alexander E., Al-Kershi, Sina, Kresbach, Catena, Schüller, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357758/ https://www.ncbi.nlm.nih.gov/pubmed/34264394 http://dx.doi.org/10.1007/s00401-021-02346-8

Ejemplares similares

Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2023)

Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
por: Schoof, Melanie, et al.
Publicado: (2023)

MEDB-11. MYC overexpression and SMARCA4 loss in cerebellar granule cell precursors cooperate to drive medulloblastoma formation in mice
por: Göbel, Carolin, et al.
Publicado: (2022)

BIOL-10. MOUSE MODELING OF PEDIATRIC MYCN GLIOMA REVEALS INTRATUMORAL HETEROGENEITY INCLUDING NEURONAL AND OLIGODENDROGLIAL LINEAGE SIGNATURES
por: Schoof, Melanie, et al.
Publicado: (2023)

Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond
por: Kresbach, Catena, et al.
Publicado: (2022)

HGG-15. Generation of a novel mouse model for brain tumors of the DNA methylation class “GBM MYCN”
por: Schoof, Melanie, et al.
Publicado: (2022)

Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017)

MODL-03. Establishment of intraventricular Shh inhibition as a therapeutic option for young patients with medulloblastoma
por: Kresbach, Catena, et al.
Publicado: (2022)

MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice
por: Göbel, Carolin, et al.
Publicado: (2023)

DIPG-42. Diffuse midline gliomas, H3K27-altered as an interdisciplinary challenge
por: Kammler, Gertrud, et al.
Publicado: (2022)

Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)

The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in mice
por: Schoof, Melanie, et al.
Publicado: (2023)

Simultaneous Brg1 Knockout and MYCN Overexpression in Cerebellar Granule Neuron Precursors Is Insufficient to Drive Tumor Formation but Temporarily Enhances their Proliferation and Delays their Migration
por: Holdhof, Dörthe, et al.
Publicado: (2021)

The first documentation of Li-Fraumeni syndrome in Korea.
por: Bang, Y. J., et al.
Publicado: (1995)

Pediatric Case of Li–Fraumeni Syndrome in Honduras
por: Martínez-Beckerat, R., et al.
Publicado: (2021)

Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome
por: Pantziarka, Pan, et al.
Publicado: (2022)

A Case of Li-Fraumeni Associated Thymoma
por: Sivayoganathan, Thibacg, et al.
Publicado: (2022)

An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
por: Tauziède-Espariat, A., et al.
Publicado: (2019)

Genotype–phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry
por: Penkert, Judith, et al.
Publicado: (2022)

Li-Fraumeni syndrome--a molecular and clinical review.
por: Varley, J. M., et al.
Publicado: (1997)

Li-Fraumeni Syndrome: A Rare Genetic Disorder
por: Tazin, Faria, et al.
Publicado: (2022)

MEDB-14. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
por: Kolodziejczak, Anna, et al.
Publicado: (2022)

Li‐Fraumeni versus Pseudo‐Li‐Fraumeni Syndrome: Key Insights for Interpreting Next‐Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes
por: Sorscher, Steven, et al.
Publicado: (2017)

Li-Fraumeni syndrome: a case report from Italy.
por: Orjuela, M., et al.
Publicado: (1990)

Li Fraumeni syndrome, cancer and senescence: a new hypothesis
por: Pantziarka, Pan
Publicado: (2013)

PEComa in a Young Patient with Known Li-Fraumeni Syndrome
por: Neofytou, Kyriakos, et al.
Publicado: (2015)

Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche
por: Pantziarka, Pan
Publicado: (2015)

Prostate Cancer and Li-Fraumeni Syndrome: Implications for Screening and Therapy
por: Spees, Colleen K., et al.
Publicado: (2015)

The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome
por: Yoshida, Tsukasa, et al.
Publicado: (2017)

MYCN Amplifications and Metabolic Rewiring in Neuroblastoma
por: Pouliou, Marialena, et al.
Publicado: (2023)

Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
por: Su, Yan, et al.
Publicado: (2020)

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
por: Ruijs, Marielle WG, et al.
Publicado: (2009)

Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
por: Lammens, C. R. M., et al.
Publicado: (2010)

Genetic and functional analysis of a Li Fraumeni syndrome family in China
por: Hu, Huaying, et al.
Publicado: (2016)

Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives
por: Kumar, Prerna, et al.
Publicado: (2018)

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020)

Difficulties of Management of Multiple Synchronous Bone Tumors in Li-Fraumeni Syndrome
por: Huby, Marine, et al.
Publicado: (2019)

Maxillary mesenchymal chondrosarcoma leading to a diagnosis of Li-Fraumeni syndrome
por: Ventura, Eduardo, et al.
Publicado: (2020)

Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
por: Kumamoto, Tadashi, et al.
Publicado: (2021)

Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
por: Li, Jiabing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fesqk7932htjtedo0e96abk9v1